TOWSE MATTHEW W 4
4 · NxStage Medical, Inc. · Filed Mar 12, 2018
Insider Transaction Report
Form 4
TOWSE MATTHEW W
Chief Financial Officer
Transactions
- Exercise/Conversion
Restricted Stock Unit
2018-03-09−5,821→ 11,643 totalExercise: $0.00From: 2018-03-09Exp: 2020-03-09→ Common Stock (5,821 underlying) - Exercise/Conversion
Common Stock
2018-03-09+5,821→ 30,242 total - Award
Restricted Stock Unit
2018-03-09+17,464→ 17,464 totalExercise: $0.00From: 2018-03-09Exp: 2020-03-09→ Common Stock (17,464 underlying) - Tax Payment
Common Stock
2018-03-09$24.37/sh−1,846$44,987→ 28,396 total
Footnotes (1)
- [F1]Award granted pursuant to the 2017 Performance Share Plan, vesting in 3 equal annual installments beginning March 9, 2018.